Balyasny Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Balyasny Asset Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-25,000	Closed	-$4.34M	–	1751
2019 Q2	$4.34M	Buy	+25,000	New	+$4.32M	0.03%	650
2018 Q2	–	Sell	-33,500	Closed	-$3.77M	–	2298
2018 Q1	$3.77M	Buy	+33,500	New	+$4.21M	0.02%	789

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Balyasny Asset Management's GWPH Position: Q2 2021 in Review

Balyasny Asset Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 457,697 shares — an estimated $99.3M sold.

Balyasny Asset Management first reported a position in GWPH in Q1 2017 and held it in 9 quarters. The position peaked at $99.3M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Balyasny Asset Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Balyasny Asset Management sold 457,697 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $99.3M.
Balyasny Asset Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2017 and held it in 9 quarters.
Balyasny Asset Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $99.3M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Balyasny Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.